Fragmin and Votrient drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fragmin (dalteparin sodium) and Votrient (pazopanib hydrochloride). Common drug interactions include hypertension among females and confusional state among males.

The phase IV clinical study analyzes what interactions people have when they take Fragmin and Votrient. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Fragmin?

Fragmin has active ingredients of dalteparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 11,999 Fragmin users. Check the latest studies of Fragmin.

What is Votrient?

Votrient has active ingredients of pazopanib hydrochloride. It is often used in metastatic renal cell carcinoma. eHealthMe is studying from 25,347 Votrient users. Check the latest studies of Votrient.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

25 people who take Fragmin and Votrient together, and have interactions are studied.

Fragmin and Votrient drug interactions.

What are the common drug interactions of Fragmin and Votrient, by gender? *:

female:

  1. Hypertension (high blood pressure)
  2. Inflammatory bowel disease
  3. Irritable bowel syndrome
  4. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  5. Lip dry
  6. Malignant neoplasm progression (cancer tumour came back)
  7. Metastases to central nervous system (cancer spreads to central nervous system)
  8. Metastases to lung (cancer spreads to lung)
  9. Pain
  10. Polyp

male:

  1. Confusional state
  2. Malignant neoplasm progression (cancer tumour came back)
  3. Urticaria (rash of round, red welts on the skin that itch intensely)
  4. Vomiting
  5. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  6. Aortic valve incompetence
  7. Atrial thrombosis (blood clot that develops in an artery)
  8. Back pain
  9. Blood pressure decreased
  10. Blood pressure increased

What are the common drug interactions of Fragmin and Votrient, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Blood pressure increased
  2. Bundle branch block (disruption in the normal flow of electrical pulses that drive the heart beat)
  3. Cardiac failure
  4. Chest pain
  5. Death
  6. Dilatation ventricular
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Dyspnoea (difficult or laboured respiration)
  9. Ejection fraction decreased (systolic heart failure)
  10. Electrocardiogram t wave inversion

30-39:

  1. Atrial thrombosis (blood clot that develops in an artery)
  2. Burning sensation
  3. Constipation
  4. Disease progression
  5. Dry mouth
  6. Dysgeusia (disorder of the sense of taste)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Hypoaesthesia teeth (reduced sense of touch or sensation)
  9. Nail discolouration (change in nail colour)
  10. Oedema peripheral (superficial swelling)

40-49:

  1. Duodenal fistula
  2. Malignant neoplasm progression (cancer tumour came back)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)

50-59:

  1. Confusional state
  2. Infection
  3. Lethargy (tiredness)
  4. Malignant neoplasm progression (cancer tumour came back)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Blood pressure decreased
  7. Brain neoplasm (tumour of brain)
  8. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  9. Chronic kidney disease
  10. Death

60+:

  1. Death
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Confusional state
  4. Decreased appetite
  5. Fatigue (feeling of tiredness)
  6. Headache (pain in head)
  7. Petechiae (a small red or purple spot caused by bleeding into the skin)
  8. Thrombosis (formation of a blood clot inside a blood vessel)
  9. Urticaria (rash of round, red welts on the skin that itch intensely)
  10. Vomiting

What are the existing conditions these people have? *

  1. Renal Cell Carcinoma (a kidney cancer): 4 people, 16.00%
  2. Renal Cancer Metastatic (cancer of kidney spreads to other part): 4 people, 16.00%
  3. Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 16.00%
  4. Lung Neoplasm Malignant (cancer tumour of lung): 4 people, 16.00%
  5. Sarcoma (rare cancers that develop in the muscle, bone, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues): 3 people, 12.00%
  6. Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 8.00%
  7. Neoplasm Malignant (cancer tumour): 2 people, 8.00%
  8. Nausea (feeling of having an urge to vomit): 2 people, 8.00%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fragmin and Votrient?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fragmin and Votrient:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fragmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Votrient:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fragmin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Votrient and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on dalteparin sodium and pazopanib hydrochloride (the active ingredients of Fragmin and Votrient, respectively), and Fragmin and Votrient (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: